Which interventions appear most often on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trial records?

Pyridostigmine Bromide is the most-linked intervention name on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome records (1 trial links), followed by Placebo. Names are sponsor-reported on ClinicalTrials.gov.

How do I find a recruiting trial for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

Use the trial list filtered by Recruiting status, or visit the trial finder to search by condition and state. Always discuss with your healthcare provider.

Is this data current?

Data is from ClinicalTrials.gov. Trial status may have changed. Always verify at ClinicalTrials.gov before making participation decisions.

Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: early-phase trial registry

Q: How many clinical trials are there for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?

PlainTrial tracks 3 US clinical trials for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, of which 2 are currently recruiting.

Compiled by PlainTrial · August 8, 2026

2 of 3 indexed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: 3 US clinical trials tracked, 2 recruiting.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Center for Complementary and Integrative Health (NCCIH), running 1 of these trials.

Enrollment posture brief

Registry condition myalgic-encephalomyelitischronic-fatigue-syndrome

Volume-matched condition peers

Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)

Open-enrollment share among volume-matched conditions near Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is recruiting above its size-band peers.

2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Open and recent trials

3 total, page 1 of 1

RECRUITING 692 participants

Patient-Centered Assessment of Symptoms and Outcomes

National Center for Complementary and Integrative Health (NCCIH)

NCT03952624

RECRUITING 200 participants

Chronic Infections and Inflammation in ME/CFS: An Observational Study

University of California, San Francisco

NCT07227441

COMPLETED Phase 2 45 participants

The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

Brigham and Women's Hospital

NCT03674541

Phase Distribution

Phase	Trial count
Phase 2	1

Top Sponsors

National Center for Complementary and Integrative Health (NCCIH) 1 trials

Brigham and Women's Hospital 1 trials

University of California, San Francisco 1 trials

Named interventions

Most-linked intervention names on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Pyridostigmine Bromide Drug

1 trials

Placebo Drug

1 trials

US sites by state

Facility locations filed on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trials. A trial with sites in several states counts in each.

Maryland 1 trials

Massachusetts 1 trials

California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Myalgic Encephalomyelitis/Chronic Fatigue Syndrome page

3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

2 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
National Center for Complementary and Integrative Health (NCCIH) sponsors the most Myalgic Encephalomyelitis/Chronic Fatigue Syndrome trials on record, review their full trial history before evaluating a specific study. See National Center for Complementary and Integrative Health (NCCIH)'s trials
Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Myalgic Encephalomyelitis/Chronic Fatigue Syndrome condition card totals 3 registered trials; most-linked intervention Pyridostigmine Bromide; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.